NUVA - NuVasive, Inc. (NASDAQ Stock)

[greencat]

NUVA if it breaks tendline is a buy short term. Must hold support or then its a sell.


NUVA Chart



NuVasive, Inc.
7475 Lusk Boulevard
San Diego, CA 92121
United States - Map
Phone: 858-909-1800
Fax: 858-909-2000
Web Site: NuVasive - Creative Spine Technology - Patients | Surgeons | Investors

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 444


BUSINESS SUMMARY
NuVasive, Inc., a medical device company, engages in the design, development, and marketing of products for the surgical treatment of spine disorders. Its products are used in applications for spine fusion surgery. The company’s products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines four categories of product offerings, including NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a split-blade design retraction system providing enhanced surgical access to the spine; Biologics, which includes FormaGraft and Osteocel line of products; and specialized implants, such as SpheRx pedicle screw system, and CoRoent suite of implants, a titanium surgical mesh system with a line of precision-machined cervical and lumbar allograft implants, and related instrumentation. NuVasive also offers a range of bone allograft in patented saline packaging and spine implants, such as rods, plates, and screws, as well as Osteocel, a bone matrix product that offers three properties related to autograft, including osteoconduction, osteoinduction, and osteogenesis. The company’s motion preservation products include lateral total disc replacement (TDR). It sells its products through independent sales agencies and direct sales representatives primarily in the United States. The company was founded in 1997 and is headquartered in San Diego, California.